港股異動丨AI醫療股拉昇 醫脈通大漲超17% 醫渡科技漲超7%
港股AI醫療股拉昇走強,其中,醫脈通一度大漲超17%,醫渡科技漲超7%,固生堂漲6.8%,晶泰控股、京東健康漲超5%,阿里健康、平安好醫生漲超3%。消息上,DeepSeek接入醫療領域,AI+醫療概念持續活躍。機構指出,AI醫療市場潛力較大,隨着生成式AI技術革新,高效的訓練和推理方法、低成本的預訓練策略,較好地解決了醫學模型訓練數據規模大、成本高的難題,爲AI醫療的多場景應用奠定基礎。2020年以來多部門從標準化建設、技術創新、數據應用等多個方面爲AI醫療的發展提供助力。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.